Jadwal Sholat

Memuat jadwal sholat…

Teknik & Rekayasa editorial

Open AccessOA2024

Advances in Electrospun Poly(ε-caprolactone)-Based Nanofibrous Scaffolds for Tissue Engineering

This review summarizes recent advances in electrospun poly(ε-caprolactone) (PCL)-based nanofibrous scaffolds, focusing on fabrication methods, property enhancement, and tissue engineering applications. It highlights how blending, layering, and surface modification overcome PCL's limitations in cell adherence and wettability.
Karla N. Robles; Fatima Tuz Zahra; Richard R Mu; T. Giorgio· Polymers· 2024· DOI 10.3390/polym16202853

The core problem

Tissue engineering offers a promising approach to restore damaged tissues caused by injury or disease. Scaffolds are essential in this context, providing structural support for cell growth and guiding tissue regeneration. For successful tissue formation, scaffolds must be biocompatible and nontoxic. Poly(ε-caprolactone) (PCL) is a biodegradable and mechanically strong biopolymer widely used as a key component in composite scaffolds. However, PCL alone suffers from low cell adherence and wettability, which can limit its efficacy. To address these drawbacks, PCL is often blended with other biomaterials or modified to achieve synergistic properties. This review focuses on electrospun PCL-based scaffolds, including single and blended nanofibers, as well as multi-layered architectures such as core-shell and multi-layered nanofibers. The review covers fabrication techniques, tunable properties (e.g., fiber diameter, composition, mechanical properties, biocompatibility, drug-loading capacity), and enhancement strategies (layering, surface modification, coating) reported in recent literature.

Innovation

The authors conducted a literature review of recent studies on electrospun PCL-based scaffolds for tissue engineering. The review encompasses various fabrication approaches, including electrospinning of single-component PCL, blends of PCL with other polymers or biomaterials, and advanced architectures like core-shell and multi-layered nanofibers. The review also examines post-processing techniques such as scaffold layering, surface modification, and coating to enhance properties like wettability, mechanical strength, and biocompatibility. Key parameters such as nanofiber diameter, composition, and mechanical properties are discussed in relation to scaffold performance. The review synthesizes findings from the literature to provide a comprehensive overview of the state of the art.
Introduction
Tissue engineering offers a promising approach to restore damaged tissues caused by injury or disease. Scaffolds are essential in this context, providing structural support for cell growth and guiding tissue regeneration. For successful tissue formation, scaffolds must be biocompatible and nontoxic. Poly(ε-caprolactone) (PCL) is a biodegradable and mechanically strong biopolymer widely used as a key component in composite scaffolds. However, PCL alone suffers from low cell adherence and wettability, which can limit its efficacy. To address these drawbacks, PCL is often blended with other biomaterials or modified to achieve synergistic properties. This review focuses on electrospun PCL-based scaffolds, including single and blended nanofibers, as well as multi-layered architectures such as core-shell and multi-layered nanofibers. The review covers fabrication techniques, tunable properties (e.g., fiber diameter, composition, mechanical properties, biocompatibility, drug-loading capacity), and enhancement strategies (layering, surface modification, coating) reported in recent literature.

Why it matters

The review highlights the versatility of electrospun PCL-based scaffolds and the importance of composite and multi-layered architectures in overcoming the limitations of pure PCL. The synergistic effects of blending and surface modification are crucial for achieving the desired balance of mechanical properties, biocompatibility, and bioactivity. The authors emphasize that scaffold properties can be finely tuned through fabrication parameters and post-processing, making PCL-based scaffolds suitable for a wide range of tissue engineering applications. However, challenges remain, such as optimizing degradation rates and achieving precise control over drug release. Future research directions may include the development of more sophisticated multi-functional scaffolds and the integration of bioactive molecules for enhanced tissue regeneration. Overall, the review underscores the potential of electrospun PCL-based scaffolds as a promising platform for tissue engineering.

Who should read this

Pembaca Research Digest dan praktisi rumpun ini.

Opening member content…